PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.55%
Revenue growth above 1.5x AVGO's 1.23%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
10.73%
Positive gross profit growth while AVGO is negative. John Neff would see a clear operational edge over the competitor.
18.30%
Positive EBIT growth while AVGO is negative. John Neff might see a substantial edge in operational management.
18.21%
Positive operating income growth while AVGO is negative. John Neff might view this as a competitive edge in operations.
5.92%
Net income growth under 50% of AVGO's 84.10%. Michael Burry would suspect the firm is falling well behind a key competitor.
6.06%
EPS growth under 50% of AVGO's 83.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
6.19%
Diluted EPS growth under 50% of AVGO's 92.98%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.40%
Share reduction while AVGO is at 1.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.39%
Reduced diluted shares while AVGO is at 0.68%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth under 50% of AVGO's 0.39%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
15.35%
Similar OCF growth to AVGO's 17.00%. Walter Schloss would assume comparable operations or industry factors.
14.67%
FCF growth 50-75% of AVGO's 29.09%. Martin Whitman would see if structural disadvantages exist in generating free cash.
55.93%
10Y revenue/share CAGR under 50% of AVGO's 584.60%. Michael Burry would suspect a lasting competitive disadvantage.
27.00%
5Y revenue/share CAGR under 50% of AVGO's 339.67%. Michael Burry would suspect a significant competitive gap or product weakness.
20.87%
3Y revenue/share CAGR under 50% of AVGO's 272.28%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
47.63%
10Y OCF/share CAGR under 50% of AVGO's 1173.64%. Michael Burry would worry about a persistent underperformance in cash creation.
55.81%
Below 50% of AVGO's 354.24%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
27.49%
3Y OCF/share CAGR under 50% of AVGO's 292.80%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
150.27%
Below 50% of AVGO's 853.70%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
171.55%
5Y net income/share CAGR above 1.5x AVGO's 98.81%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
66.59%
3Y net income/share CAGR similar to AVGO's 73.45%. Walter Schloss would attribute it to shared growth factors or demand patterns.
34.68%
Below 50% of AVGO's 1260.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.06%
Below 50% of AVGO's 442.73%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.24%
Below 50% of AVGO's 283.59%. Michael Burry suspects a serious short-term disadvantage in building book value.
526.04%
Dividend/share CAGR of 526.04% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
192.90%
Below 50% of AVGO's 726.83%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
66.12%
Below 50% of AVGO's 300.26%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
9.87%
AR growth well above AVGO's 6.47%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.64%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.88%
Asset growth above 1.5x AVGO's 0.47%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.05%
BV/share growth above 1.5x AVGO's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
6.70%
Debt growth far above AVGO's 0.04%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.44%
R&D growth drastically higher vs. AVGO's 2.60%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-1.14%
We cut SG&A while AVGO invests at 1.49%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.